The current treatment protocol for unresectable recurrent or metastatic HNSCC consists of surgical techniques, radiotherapy, chemotherapy drugs, or chemotherapy associated with EGFR-targeted therapy (cetuximab) and, recently, ICIs. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.